Article Details

Analyst Reaffirms Positive Outlook on PTC Therapeutics with Adjusted Price Target

Retrieved on: 2023-09-18 18:34:04

Tags for this article:

Click the tags to see associated articles and topics

Analyst Reaffirms Positive Outlook on PTC Therapeutics with Adjusted Price Target. View article details on hiswai:

Excerpt

On September 18, 2023, Barry Jonas, an analyst at Truist Securities, reaffirmed his positive outlook on PTC Therapeutics (NASDAQ: PTCT) by ...

Article found on: beststocks.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up